http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006287285-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be3694fda3faa3a67592e8495d1e0e8b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
filingDate 2006-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7307eaa1b37c70374b8fe3a8e5d8fb2b
publicationDate 2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2006287285-A1
titleOfInvention Methods and Compositions for the Treatment of Pain and Other Hormone-Allergy-Related Symptoms Using Dilute Hormone Solutions
abstract A method and composition for the treatment of hormone allergy is disclosed. The method relates to using progesterone dilutions, or any other steroid hormone, to treat the systemic symptoms of hormone allergy, including pain. The composition of the hormone dilutions ranges from 10 −1 to 10 −5 . The hormone dilution may be administered sublingually, or, in the alternative, an intradermal route of administration may be chosen. Hormone dilutions may be administered at daily intervals or on any other treatment schedule as required to alleviate a patient's symptoms.
priorityDate 2001-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6207646-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7179798-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007037782-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5744463-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5834521-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5084277-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6043236-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003148987-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6936599-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005065136-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5869081-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6040340-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5108995-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6290957-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6378526-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4596795-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004105858-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002164314-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5855920-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016

Total number of triples: 37.